Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.44 -0.07 (-2.95%) As of 09:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oramed Pharmaceuticals Stock Price Performance The Oramed Pharmaceuticals (ORMP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 3.66%, with a year-to-date return of 0.66%. In the past month, the stock has increased 9.24%, reflecting recent market activity. As of the latest close, Oramed Pharmaceuticals traded at $2.44 with a market cap of $100.04 million and volume of 134,983 shares. Five years ago, the stock traded at $2.57, representing a 5.21% decrease over that period. At the time, it had a market cap of $60.46 million and a volume of 37,357 shares. Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-4.47%1 Month Performance+9.24%3 Month Performance+11.54%Year-To-Date Performance+0.66%1 Year Performance+3.66%5 Year Performance-5.21% ORMP Stock Chart for Monday, October, 6, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$2.51$2.44-2.79%$2.57$2.39134,983 shs$100.04 million10/02/2025$2.55$2.51-1.57%$2.57$2.4085,248 shs$102.91 million10/01/2025$2.64$2.55-3.41%$2.67$2.55142,806 shs$104.56 million09/30/2025$2.70$2.64-2.22%$2.68$2.53168,864 shs$108.24 million09/29/2025$2.41$2.70+12.03%$2.73$2.37388,473 shs$110.70 million09/26/2025$2.40$2.41+0.42%$2.43$2.3431,816 shs$98.81 million09/25/2025$2.40$2.40$2.41$2.28120,148 shs$98.41 million09/24/2025$2.49$2.40-3.61%$2.50$2.39110,218 shs$98.40 million09/23/2025$2.47$2.49+0.81%$2.50$2.3551,208 shs$102.09 million09/22/2025$2.34$2.47+5.56%$2.48$2.34109,422 shs$101.28 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$2.44$2.34-4.10%$2.50$2.34252,657 shs$95.95 million09/18/2025$2.27$2.44+7.49%$2.45$2.2574,875 shs$100.04 million09/17/2025$2.29$2.27-0.87%$2.30$2.2434,066 shs$93.07 million09/16/2025$2.32$2.29-1.29%$2.32$2.2717,268 shs$93.90 million09/15/2025$2.41$2.32-3.73%$2.37$2.27106,407 shs$95.12 million09/12/2025$2.43$2.41-0.82%$2.43$2.37102,555 shs$98.81 million09/11/2025$2.33$2.43+4.29%$2.45$2.33245,395 shs$99.63 million09/10/2025$2.31$2.33+0.87%$2.33$2.2970,375 shs$95.54 million09/09/2025$2.30$2.31+0.43%$2.32$2.26139,493 shs$94.71 million09/08/2025$2.23$2.30+3.14%$2.30$2.23119,022 shs$94.30 million09/05/2025$2.22$2.23+0.45%$2.25$2.1758,883 shs$91.43 million Related Companies 4D Molecular Therapeutics Stock Chart Y-mAbs Therapeutics Stock Chart Evolus Stock Chart Kamada Stock Chart Aura Biosciences Stock Chart Korro Bio Stock Chart Design Therapeutics Stock Chart Bright Minds Biosciences Stock Chart Annexon Stock Chart Lexeo Therapeutics Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
